These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1219 related items for PubMed ID: 10965808
1. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma. Altinyollar H, Kapucuoglu N, Pak I, Berberoglu U. J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808 [Abstract] [Full Text] [Related]
4. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Changsri C, Prakash S, Sandweiss L, Bose S. Breast J; 2004 Jun; 10(5):392-7. PubMed ID: 15327491 [Abstract] [Full Text] [Related]
5. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F. Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092 [Abstract] [Full Text] [Related]
7. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Guenther JM, Krishnamoorthy M, Tan LR. Cancer J Sci Am; 1997 Jun; 3(6):336-40. PubMed ID: 9403045 [Abstract] [Full Text] [Related]
8. Lymph node metastasis in patients with frozen section analyses that are negative for tumors. Lee SK, Lee KW, Kim S, Choi MY, Kim J, Lee J, Jung SP, Choe JH, Kim JH, Kim JS, Lee JE, Yang JH, Nam SJ. Oncology; 2012 Jun; 83(1):31-7. PubMed ID: 22722529 [Abstract] [Full Text] [Related]
9. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Pendas S, Dauway E, Cox CE, Giuliano R, Ku NN, Schreiber RH, Reintgen DS. Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202 [Abstract] [Full Text] [Related]
12. Histopathologic analysis of sentinel lymph nodes in breast carcinoma. Hsieh PP, Ho WL, Yeh DC, Liu TJ, Wu CC, Lin JH, Wang SJ. Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431 [Abstract] [Full Text] [Related]
13. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up. Kiluk JV, Ly QP, Santillan AA, Meade T, Ramos D, Reintgen DS, Dessureault S, Davis M, Shamehdi C, Cox CE. Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043 [Abstract] [Full Text] [Related]
14. Anatomopathological analysis of sentinel and nonsentinel lymph nodes in breast cancer: hematoxylin-eosin versus immunohistochemistry. Soares CT, Frederigue-Junior U, Luca LA. Int J Surg Pathol; 2007 Oct; 15(4):358-68. PubMed ID: 17913942 [Abstract] [Full Text] [Related]
15. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M. Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047 [Abstract] [Full Text] [Related]
17. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Teng S, Dupont E, McCann C, Wang J, Bolano M, Durand K, Peltz E, Bass SS, Cantor A, Ku NN, Cox CE. Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134 [Abstract] [Full Text] [Related]
19. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up. Takeshita T, Tsuda H, Moriya T, Yamasaki T, Asakawa H, Ueda S, Sato K, Aida S, Tamai S, Matsubara O, Hase K, Yamamoto J. Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659 [Abstract] [Full Text] [Related]